Cannabinoid biosynthesis

Normal 0 14 false false false IT X-NONE AR-SA

/* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:Arial; mso-bidi-theme-font:minor-bidi;} Phytocannabinoids are secondary metabolites that interact with the endocannabinoid system, which regulates neurotransmitter release and action both in the central nervous system and in the periphery. Many different regulatory actions have been attributed to cannabinoids, and their involvement in several pathophysiological conditions is under intense scrutiny. They act mainly on modulation of pain, anxiety, appetite and muscle spasticity.